Avacta Group Plc (LON:AVCT – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 58.93 ($0.72) and traded as low as GBX 51 ($0.62). Avacta Group shares last traded at GBX 52 ($0.64), with a volume of 1,090,990 shares traded.
Avacta Group Stock Up 3.1 %
The firm has a 50 day moving average of GBX 48.57 and a two-hundred day moving average of GBX 58.93. The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 63.54. The stock has a market capitalization of £186.32 million, a PE ratio of -577.78 and a beta of 1.12.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Read More
- Five stocks we like better than Avacta Group
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- How to Start Investing in Real Estate
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- P/E Ratio Calculation: How to Assess Stocks
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
